Abstract
Vladimir Markovich Kenis, Pavel Shpulev, Evgenia Melnik, Irina Sosnina, Evgeniia V. Snegova
Abstract
Authors
Institutions
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Analysis of data from the registry of children with idiopathic congenital clubfoot in Saint Petersburg from 2020 to 2024
10.17816/ptors701316 · 2026
Comparison of Ponseti versus surgical treatment for idiopathic clubfoot: A short-term preliminary report
10.1007/s11999-009-0819-5 · 2009
Modern concepts of conservative treatment methods of clubfoot
10.17816/ptors2420-31 · 2014
The etiology of idiopathic congenital talipes equinovarus: A systematic review
10.1186/s13018-018-0913-z · 2018
Functional Assessment of Clubfoot Associated HOXA9, TPM1, and TPM2 Variants Suggests a Potential Gene Regulation Mechanism
10.1007/s11999-016-4788-1 · 2016
Prenatal Diagnosis and Functional Analysis of Two Compound Heterozygous Variants in the KLHL40 Gene Causing Nemaline Myopathy 8
10.1002/mgg3.70270 · 2026
Genetic Role in Recurrence of Idiopathic CTEV: A Systematic Review
2023
The genetics of isolated and syndromic clubfoot
10.1302/1863-2548.13.190063 · 2019
Whole Exome Sequencing in Individuals with Idiopathic Clubfoot Reveals a Recurrent Filamin B (FLNB) Deletion
10.1097/corr.0000000000001957 · 2022
Provenance
crossref
Confidence 100%
ror
Confidence 99%
ror
Confidence 99%
ror
Confidence 99%
ror
Confidence 99%
openalex
Confidence 95%
datacite
Confidence 0%
Diagnosis and management of Duchenne muscular dystrophy, part 1: Diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management
10.1016/s1474-4422(18)30024-3 · 2018
Orthopedic management in Duchenne muscular dystrophy
10.1016/s0929-693x(25)00251-9 · 2025
Current Concepts in the Orthopedic Management of Duchenne Muscular Dystrophy
2024
Downstream Pathways of Dystrophin Deficiency in Duchenne Muscular Dystrophy: Implications for Muscle Degeneration and Regeneration
10.1002/jcsm.70333 · 2026
Intrinsic dysfunction in muscle stem cells lacking dystrophin begins during secondary myogenesis
10.1038/s41467-025-64999-3 · 2025
Muscular dystrophy begins early in embryonic development deriving from stem cell loss and disrupted skeletal muscle formation
10.1242/dmm.001008 · 2009
The evolving genetic landscape of neuromuscular fetal akinesias
10.1177/22143602251339357 · 2025
Is webbing (pterygia) a constant feature in patients with Escobar syndrome?
10.1111/os.12064 · 2013
Fetal Akinesia/Hypokinesia and Arthrogryposis of Neuromuscular Origin: Etiologic Groups, Genetics, and Phenotypic Spectrum
10.1002/acn3.70088 · 2025
Dystrophin and utrophin: Genetic analyzes of their role in skeletal muscle
10.1002/(sici)1097-0029(20000201/15)48:3/4<155::aid-jemt4>3.0.co;2-0 · 2000
10.3389/fgene.2025.1664424
10.3389/fgene.2025.1664424
Role of genetic determinants in the development of congenital scoliosis: A review
10.17816/ptors636350 · 2025
Genetics of clubfoot
10.1097/bpb.0b013e328349927c · 2012
Usefulness and accessibility of information on the treatment of children with congenital clubfoot: Results of a survey of parents
10.17816/ptors634027 · 2024
Clinical and radiological variants of the nail–patella syndrome: Why is it important to make a correct diagnosis?
10.17816/ptors630082 · 2024
Assessment of the frequency of fibrodysplasia ossificans progressiva (FOP) in Russia
2025
Fibrodysplasia ossificans progressiva: Clinical and genetic aspects
10.1186/1750-1172-6-80 · 2011
A Review of Muscle Relaxants in Anesthesia in Patients with Neuromuscular Disorders Including Guillain-Barré Syndrome, Myasthenia Gravis, Duchenne Muscular Dystrophy, Charcot-Marie-Tooth Disease, and Inflammatory Myopathies
10.12659/msm.945675 · 2024
Reação atípica à anestesia em dystrophia muscular de Duchenne/Becker [Atypical reaction to anesthesia in Duchenne/Becker muscular dystrophy]
10.1016/j.bjan.2017.04.015 · 2018
Neuromuscular conditions associated with malignant hyperthermia in pediatric patients: A 25-year retrospective study
10.1016/j.nmd.2016.02.007 · 2016
Anesthesia and Duchenne or Becker muscular dystrophy: Review of 117 anesthetic exposures
10.1111/pan.12248 · 2013
Treatment of the Lower Extremity Contracture/Deformities
10.1097/bpo.0000000000001005 · 2017
10.3390/genes17050533
10.3390/genes17050533
Rewriting Duchenne muscular dystrophy therapy
10.1016/j.cell.2026.06.011 · 2026
Gene-based therapies for neuromuscular disorders
2024
10.1136/jnnp-2026-339071
10.1136/jnnp-2026-339071
Change in respiratory outcomes in adults with Duchenne muscular dystrophy in the era of corticosteroids
10.1177/22143602251386096 · 2026
10.1371/journal.pone.0345550
10.1371/journal.pone.0345550
Delayed diagnosis and genetic testing in spinal muscular atrophy: A case series
10.1080/07853890.2026.2728198 · 2026
Treating neuromuscular diseases: Unveiling gene therapy breakthroughs and pioneering future applications
10.1186/s12929-025-01123-z · 2025
Gene Therapy for Neuromuscular Diseases: Health Economic Challenges and Future Perspectives
10.3233/jnd-221540 · 2022
10.3390/biomedicines12040912
10.3390/biomedicines12040912 · doi-reference
10.3390/ijms26083579
10.3390/ijms26083579 · doi-reference
Selective immunosuppressant tofacitinib in a child with multiple epiphyseal dysplasia associated with osteoarthritic changes: A case report
10.17816/ptors688792 · doi-reference